Patrick Wagner, MD
Dr. Patrick Wagner is a surgical oncologist and the director of Complex General Surgical Oncology at Allegheny Health Network Cancer Institute in Pittsburgh, Pennsylvania. He specializes in treating abdominal cancers, gastric cancers, peritoneal cancers including malignant peritoneal mesothelioma, and other malignancies using minimally invasive approaches including robotic surgery and advanced complex surgical procedures including cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.[1]
Dr. Wagner prioritizes patient-centered, individualized care and works to use innovative treatment options that match patients’ diagnoses, conditions, and goals.
Education and Career
Dr. Wagner is a graduate of the University of Pittsburgh and received his medical degree degree from the Harvard Medical School. He completed residencies in General Surgery and Anatomic Pathology and served as Administrative Chief Resident at New York Presbyterian Hospital/Weill Cornell Medical Center. He completed a fellowship in Surgical Oncology, concentrating on translational research, under Dr. Bartlett’s leadership at the University of Pittsburgh Medical Center.[1]
Professional Memberships and Activities
In addition to his role at Allegheny Health Network, Dr. Wagner is a member of several professional medical organizations, including:
- American College of Surgeons – Fellow
- Society of Surgical Oncology
- Society for Surgery of the Alimentary Tract
- United States and Canadian Academy of Pathologists
- American Society of Clinical Oncology
Dr. Wagner is also the Program Director of Allegheny Health Network’s Complex General Surgical Oncology Fellowship program.
Research
Dr. Wagner is involved in translational research and clinical trials investigating minimally invasive approaches including robotic surgery.[1] He is the principal investigator for a clinical trial, Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer that began enrollment on January 30, 2024.[2]
Dr. Wagner’s recent publications include:[2]
Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis. Neda Dadgar, Christopher Sherry, Jenna Zimmerman, Hyun Park, Catherine Lewis, Albert Donnenberg, Ali H Zaidi, Yong Fan, Kunhong Xiao, Vera Donnenberg, David Bartlett, …>; Journal of Translational Medicine. 2024 Apr 30
Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent: Final Results from a Phase II Study. Madeline T Olson, Brian Madajewski, Brian Ostrander, Kartik Krishnan, Patrick Wagner, Edward A Levine, Alex C Kim, Perry Shen, Nicole D Fleming, Shannon N Westin, Laur…>; Annals of Surgical Oncology. 2024 Apr 15
Assessing the long-term priorities of pancreaticoduodenectomy survivors. Edward A Joseph, Kara D Bowers, Rebecca Marcus, Bibek Aryal, Suzanne C Schiffman, Patrick L Wagner, Sricharan Chalikonda, David L Bartlett, Casey J Allen>; HPB. 2024 May 1
